Lv55
830 积分 2024-05-31 加入
From TCR fundamental research to innovative chimeric antigen receptor design
25天前
已完结
Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma
25天前
已完结
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-engineered T cell-mediated antitumor activity
1个月前
已完结
In vivo CAR T cells move into clinical trials
1个月前
已完结
Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production
2个月前
已完结
Engineered T cell therapy for central nervous system injury
2个月前
已完结
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
4个月前
已完结
Comparative analysis of rule elements for transportation of cell therapy products among regulations and standards
4个月前
已关闭
Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs
5个月前
已完结
Enhancing antitumor response by efficiently generating large-scale TCR-T cells targeting a single epitope across multiple cancer antigens
5个月前
已完结
皖公网安备34019202002308
